Executive brief
Computer system validation services are becoming more important as life sciences organizations manage larger digital ecosystems, faster release cycles, and tighter regulatory scrutiny. Validation is no longer limited to a one-time testing effort. It now spans the full system lifecycle, from planning and implementation through change control, upgrades, and retirement.
That shift is part of a broader market trend. Research and Markets reports the global computer system validation market was valued at US$3.8 billion in 2024 and is projected to reach US$6.1 billion by 2030, growing at a 8.2% CAGR. For regulated companies, the driver is simple: computerized systems now sit at the center of quality, manufacturing, clinical, lab, and business operations, so validation has become a core operational discipline.
For life sciences companies, the real question is not whether validation matters. It is whether the current approach can keep pace with modern platforms, cloud releases, automation, and risk-based expectations.
Computer system validation services help regulated organizations ensure that systems consistently perform as intended, protect data integrity, and meet applicable compliance requirements. In practice, those services often include validation planning, risk assessment, requirements traceability, testing, documentation, change control support, vendor oversight, and ongoing compliance monitoring.
Alignment with FDA expectations, including 21 CFR Part 11 and risk-based validation principles
As system landscapes become more complex, many organizations are rethinking whether an in-house-only model is still the best fit.
Managing validation entirely in-house often creates resource strain, inconsistent execution, and long-term cost pressure. Internal teams must maintain tools, templates, training, and institutional knowledge while also keeping up with regulatory changes, platform updates, and shifting business priorities.